Last updated: June 13, 2026
Back to directoryAI care-management voice agent and vocal-biomarker platform for supervised patient engagement, assessments, care coordination, and behavioral-health screening support.
Organizations that need scalable care-management outreach, quality-measure support, enrollment workflows, and behavioral-health signal detection while preserving clinical oversight and escalation rules.
Compare within workflow: Patient access, triage, and agents · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Ellipsis Health Sage as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat as high-risk patient-facing care-management and behavioral-health support. Verify whether the deployment is operational outreach, clinical assessment support, mental health screening, or decision support, and confirm no workflow implies autonomous diagnosis, treatment, or emergency response without appropriate regulatory and clinical review. |
|---|---|
| Privacy | Review BAA and customer terms, call recording consent, audio and transcript redaction, PHI and consumer health data processing, metadata use, deletion rights, service providers, Salesforce or partner data flows, retention, support access, model training, and whether public privacy claims match the contracted deployment. |
| Evidence | Use published voice-biomarker studies as starting evidence only. Require local validation for call type, language, population, PHQ-8 or GAD-7 correlation, subgroup performance, escalation accuracy, patient satisfaction, and whether automated outreach improves outcomes rather than only contact volume. |
| Workflow | Best governed with care-management, behavioral health, nursing, quality, privacy, legal, and patient-experience owners defining approved scripts, consent language, forbidden clinical advice, escalation queues, clinician review, complaint handling, and post-launch monitoring. |
Ellipsis Health describes Sage as an AI Care Manager for health plans, health systems, specialty care, and pharma workflows, with autonomous patient calls for enrollment, assessments, surveys, clinical support, adherence, and transitions of care. Its product, FAQ, ethical AI, privacy, and consumer-health-data pages describe healthcare-specific security claims, HIPAA and SOC 2 Type 2 posture, clinical oversight, ethics review, encryption, consent and deletion rights, and consumer health data handling. A 2025 JMIR AI study with Highmark evaluated semantic and acoustic speech analysis for depression severity across more than 2,000 real-world care-management calls, reporting PHQ-8 prediction performance that buyers should validate against their own population and use case.
Not for: Emergency mental health response, autonomous diagnosis, replacing licensed care managers or clinicians, unsupervised treatment advice, or using voice biomarkers without consent, workflow boundaries, and local validation.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
Digital mental health company building chat-based AI wellness tools and investigational behavioral-health digital therapeutics with published AI, safety, privacy, and regulatory disclosures.
Clinical AI primary care platform for health-system digital front doors, symptom collection, EHR-prepared visits, virtual care, and clinician-reviewed recommendations.
White-label health AI assistant from b.well that helps organizations embed conversational experiences grounded in connected patient health data.
AI-powered mental health assessment platform that uses a bot-administered conversation plus text, audio, and video signals to support supervised screening workflows.